News
All the latest news from Quadratech Diagnostics. If you would like to receive updates via our newsletter then please sign up here.
Showing Category: Industry News
Haemostasis March 2025 News
Our round-up of the latest developments from across the haemostasis industry for March 2025. REGULATORY Genentech’s TNKase (tenecteplase, tissue plasminogen activator) was approved by the FDA for the treatment of acute ischemic stroke (AIS) in adults, administered as a single 5-second intravenous (IV) bolus (3 Mar) Sanofi / Alnylam’s Qfitlia (fitusiran, antithrombin RNAi) was approved by […]
Haemostasis January & February 2025 News
Our round-up of the latest developments from across the haemostasis industry for January & February 2025. REGULATORY Star Therapeutics’ VGA039 (Protein S mAb) granted FDA Fast Track designation for the treatment of Von Willebrand disease (VWD) (7 Jan) Sobi / Sanofi’s Altuvoct (efanesoctocog alfa, recombinant Factor VIII) was authorised by MHRA to treat and prevent […]
Haemostasis November & December 2024 Industry News
Our round-up of the latest developments from across the haemostasis industry for November & December 2024, including key readouts at ASH2024 REGULATORY Vaderis Therapeutics’ VAD044 (AKT inhibitor) granted FDA Fast Track designation for the treatment of Hereditary Haemorrhagic Telangiectasia (HHT) (18 Nov) Kedrion Biopharma announced that the FDA approved the company’s manufacturing facility in Bolognana, […]
Haemostasis October 2024 Industry News
Stay up-to-speed with our monthly round-up of the latest developments from across the haemostasis industry.
